SUMMARY

Introduction: Symptomatic severe aortic stenosis is associated with high mortality. While the treatment of choice for this disease is surgical valve replacement, it cannot, however, be performed on all patients. Hence, transcatheter aortic valve implantation (TAVI) has been proposed as an alternative treatment option in patients with high surgical risk or contraindication to surgery.

Objective: To draw up quality indicators for the use of TAVI in treating symptomatic severe aortic stenosis, based on available scientific evidence and expert opinion.

Methods: The modified RAND/UCLA method (i.e., without any face-to-face meeting) was used. In a first stage, a list of proposed indicators and reference standards was drawn up on the basis of systematic review of the literature; in the second stage the proposed indicators were then assessed by a group of experts over the course of 2 scoring round

Result: see pdf below